{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:10:43Z","timestamp":1790064643391,"version":"4.0.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"19","funder":[{"DOI":"10.13039\/100013699","name":"Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013699","name":"Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013699","name":"Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013699","name":"Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Heterozygous mutations in the BRCA1 gene predispose women to breast and ovarian cancer, while biallelic BRCA1 mutations are a cause of Fanconi anemia (FA), a rare genetic disorder characterized by developmental abnormalities, early-onset bone marrow failure, increased risk of cancers, and hypersensitivity to DNA-crosslinking agents. BRCA1 is critical for homologous recombination of DNA double-strand breaks (DSB). Through its coiled-coil domain, BRCA1 interacts with an essential partner, PALB2, recruiting BRCA2 and RAD51 to sites of DNA damage. Missense mutations within the coiled-coil domain of BRCA1 (e.g., L1407P) that affect the interaction with PALB2 have been reported in familial breast cancer. We hypothesized that if PALB2 regulates or mediates BRCA1 tumor suppressor function, ablation of the BRCA1\u2013PALB2 interaction may also elicit genomic instability and tumor susceptibility. We generated mice defective for the Brca1\u2013Palb2 interaction (Brca1 L1363P in mice) and established MEF cells from these mice. Brca1L1363P\/L1363P MEF exhibited hypersensitivity to DNA-damaging agents and failed to recruit Rad51 to DSB. Brca1L1363P\/L1363P mice were viable but exhibited various FA symptoms including growth retardation, hyperpigmentation, skeletal abnormalities, and male\/female infertility. Furthermore, all Brca1L1363P\/L1363P mice exhibited macrocytosis and died due to bone marrow failure or lymphoblastic lymphoma\/leukemia with activating Notch1 mutations. These phenotypes closely recapitulate clinical features observed in patients with FA. Collectively, this model effectively demonstrates the significance of the BRCA1\u2013PALB2 interaction in genome integrity and provides an FA model to investigate hematopoietic stem cells for mechanisms underlying progressive failure of hematopoiesis and associated development of leukemia\/lymphoma, and other FA phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>A new Brca1 mouse model for Fanconi anemia (FA) complementation group S provides a system in which to study phenotypes observed in human FA patients including bone marrow failure.<\/jats:p>\n                    <jats:p>See related commentary by Her and Bunting, p. 4044<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-20-0486","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T15:58:47Z","timestamp":1596124727000},"page":"4172-4184","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ablation of the Brca1\u2013Palb2 Interaction Phenocopies Fanconi Anemia in Mice"],"prefix":"10.1158","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-436X","authenticated-orcid":false,"given":"Dongju","family":"Park","sequence":"first","affiliation":[{"name":"1Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-5814","authenticated-orcid":false,"given":"Stephen M.","family":"Bergin","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jones","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."},{"name":"3The James Polaris Molecular Laboratory, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio."},{"name":"4Division of Molecular Pathology, Department of Pathology, The Ohio State University, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ru","sequence":"additional","affiliation":[{"name":"3The James Polaris Molecular Laboratory, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0004-2617","authenticated-orcid":false,"given":"Christopher S.","family":"Koivisto","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jun","family":"Jeon","sequence":"additional","affiliation":[{"name":"1Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio."},{"name":"5Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-6171","authenticated-orcid":false,"given":"Gina M.","family":"Sizemore","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."},{"name":"6Department of Radiation Oncology, The Ohio State University, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raleigh D.","family":"Kladney","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Hadjis","sequence":"additional","affiliation":[{"name":"1Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Shakya","sequence":"additional","affiliation":[{"name":"2The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-2585","authenticated-orcid":false,"given":"Thomas","family":"Ludwig","sequence":"additional","affiliation":[{"name":"1Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"2022061706325962500_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat Res"},{"key":"2022061706325962500_bib2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng1458","article-title":"X-linked inheritance of Fanconi anemia complementation group B","volume":"36","author":"Meetei","year":"2004","journal-title":"Nat Genet"},{"key":"2022061706325962500_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","article-title":"The Fanconi anaemia pathway: new players and new functions","volume":"17","author":"Ceccaldi","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706325962500_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2159-8290.CD-12-0421","article-title":"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer","volume":"3","author":"Domchek","year":"2013","journal-title":"Cancer Discov"},{"key":"2022061706325962500_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype","volume":"5","author":"Sawyer","year":"2015","journal-title":"Cancer Discov"},{"key":"2022061706325962500_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejmg.2017.11.003","article-title":"Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients","volume":"61","author":"Freire","year":"2018","journal-title":"Eur J Med Genet"},{"key":"2022061706325962500_bib7","first-page":"3329","article-title":"Homozygous unclassified variant in a patient with non-Fanconi anemia: a case report","volume":"15","author":"Bondavalli","year":"2018","journal-title":"Oncol Lett"},{"key":"2022061706325962500_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2015-03-635599","article-title":"Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice","volume":"127","author":"Vasanthakumar","year":"2016","journal-title":"Blood"},{"key":"2022061706325962500_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.celrep.2016.12.075","article-title":"Distinct Brca1 mutations differentially reduce hematopoietic stem cell function","volume":"18","author":"Mgbemena","year":"2017","journal-title":"Cell Rep"},{"key":"2022061706325962500_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1209909","article-title":"BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity","volume":"334","author":"Shakya","year":"2011","journal-title":"Science"},{"key":"2022061706325962500_bib11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gad.879201","article-title":"Tumorigenesis in mice carrying a truncating Brca1 mutation","volume":"15","author":"Ludwig","year":"2001","journal-title":"Genes Dev"},{"key":"2022061706325962500_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molcel.2012.02.015","article-title":"BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair","volume":"46","author":"Bunting","year":"2012","journal-title":"Mol Cell"},{"key":"2022061706325962500_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ajmg.a.61130","article-title":"A Japanese patient with RAD51-associated Fanconi anemia","volume":"179","author":"Takenaka","year":"2019","journal-title":"Am J Med Genet A"},{"key":"2022061706325962500_bib14","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1038\/ncomms9829","article-title":"A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51","volume":"6","author":"Ameziane","year":"2015","journal-title":"Nat Commun"},{"key":"2022061706325962500_bib15","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1073\/pnas.0811159106","article-title":"PALB2 is an integral component of the BRCA complex required for homologous recombination repair","volume":"106","author":"Sy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706325962500_bib16","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/npjgenmed.2016.1","article-title":"Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance","volume":"1","author":"Woods","year":"2016","journal-title":"NPJ Genom Med"},{"key":"2022061706325962500_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1088877","article-title":"BRCT repeats as phosphopeptide-binding modules involved in protein targeting","volume":"302","author":"Manke","year":"2003","journal-title":"Science"},{"key":"2022061706325962500_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","article-title":"The BRCT domain is a phospho-protein binding domain","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"2022061706325962500_bib19","doi-asserted-by":"crossref","first-page":"52914","DOI":"10.1074\/jbc.C300407200","article-title":"Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains","volume":"278","author":"Rodriguez","year":"2003","journal-title":"J Biol Chem"},{"key":"2022061706325962500_bib20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.1139476","article-title":"Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response","volume":"316","author":"Wang","year":"2007","journal-title":"Science"},{"key":"2022061706325962500_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.1381306","article-title":"Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes","volume":"20","author":"Greenberg","year":"2006","journal-title":"Genes Dev"},{"key":"2022061706325962500_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nsmb1277","article-title":"CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response","volume":"14","author":"Kim","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"2022061706325962500_bib23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.1139516","article-title":"RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites","volume":"316","author":"Sobhian","year":"2007","journal-title":"Science"},{"key":"2022061706325962500_bib24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","article-title":"PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"2022061706325962500_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","article-title":"PALB2 links BRCA1 and BRCA2 in the DNA-damage response","volume":"19","author":"Zhang","year":"2009","journal-title":"Curr Biol"},{"key":"2022061706325962500_bib26","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/MCB.01655-05","article-title":"Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes","volume":"26","author":"Malecki","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2022061706325962500_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1242\/dev.043299","article-title":"FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis","volume":"137","author":"Bernardo","year":"2010","journal-title":"Development"},{"key":"2022061706325962500_bib28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2016.383","article-title":"Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1","volume":"36","author":"Sizemore","year":"2017","journal-title":"Oncogene"},{"key":"2022061706325962500_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.stem.2013.07.017","article-title":"Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire","volume":"13","author":"Guo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022061706325962500_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2232","article-title":"Launching the T-cell-lineage developmental programme","volume":"8","author":"Rothenberg","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2022061706325962500_bib31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"2022061706325962500_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"key":"2022061706325962500_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"2022061706325962500_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/ng.188","article-title":"Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects","volume":"40","author":"McGowan","year":"2008","journal-title":"Nat Genet"},{"key":"2022061706325962500_bib35","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.celrep.2013.05.028","article-title":"Mutant mice lacking the p53 C-terminal domain model telomere syndromes","volume":"3","author":"Simeonova","year":"2013","journal-title":"Cell Rep"},{"key":"2022061706325962500_bib36","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1093\/emboj\/cdf691","article-title":"Activation of the E3 ligase function of the BRCA1\/BARD1 complex by polyubiquitin chains","volume":"21","author":"Mallery","year":"2002","journal-title":"EMBO J"},{"key":"2022061706325962500_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0959-437X(01)00269-6","article-title":"The BRCA1\/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity","volume":"12","author":"Baer","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"2022061706325962500_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nsb1001-833","article-title":"Structure of a BRCA1-BARD1 heterodimeric RING-RING complex","volume":"8","author":"Brzovic","year":"2001","journal-title":"Nat Struct Biol"},{"key":"2022061706325962500_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.molcel.2015.12.017","article-title":"Structure of BRCA1-BRCT\/Abraxas complex reveals phosphorylation-dependent BRCT dimerization at DNA damage sites","volume":"61","author":"Wu","year":"2016","journal-title":"Mol Cell"},{"key":"2022061706325962500_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/abbs\/gmw047","article-title":"Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage","volume":"48","author":"Her","year":"2016","journal-title":"Acta Biochim Biophys Sin"},{"key":"2022061706325962500_bib41","doi-asserted-by":"crossref","first-page":"20759","DOI":"10.1073\/pnas.0710061104","article-title":"Ubc13\/Rnf8 ubiquitin ligases control foci formation of the Rap80\/Abraxas\/Brca1\/Brcc36 complex in response to DNA damage","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706325962500_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2022061706325962500_bib43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.201102131","article-title":"Cell cycle regulation in hematopoietic stem cells","volume":"195","author":"Pietras","year":"2011","journal-title":"J Cell Biol"},{"key":"2022061706325962500_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022061706325962500_bib45","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","article-title":"Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"key":"2022061706325962500_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12672-010-0055-1","article-title":"Estrogen and progesterone in normal mammary gland development and in cancer","volume":"2","author":"Stingl","year":"2011","journal-title":"Horm Cancer"},{"key":"2022061706325962500_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tig.2018.12.007","article-title":"The Fanconi anemia pathway and fertility","volume":"35","author":"Tsui","year":"2019","journal-title":"Trends Genet"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/80\/19\/4172\/2797218\/4172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/80\/19\/4172\/2797218\/4172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:30:12Z","timestamp":1655479812000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/80\/19\/4172\/645839\/Ablation-of-the-Brca1-Palb2-Interaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":47,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10,2]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-20-0486","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22426212","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426209.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426218.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6512259.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426215.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6512259","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426212.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426209","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426218","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426206.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426206","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426221.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426215","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22426203","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}